ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554,117 | -1.7% | 20,417 | +11.3% | 0.03% | +3.3% |
| Q2 2023 | $563,956 | -10.4% | 18,346 | +5.0% | 0.03% | -23.1% |
| Q1 2023 | $629,444 | -24.7% | 17,470 | -17.4% | 0.04% | -27.8% |
| Q4 2022 | $835,453 | +2.3% | 21,140 | +4.0% | 0.05% | -8.5% |
| Q3 2022 | $817,000 | -17.6% | 20,323 | -13.8% | 0.06% | -6.3% |
| Q2 2022 | $992,000 | +3.3% | 23,587 | -4.2% | 0.06% | +57.5% |
| Q1 2022 | $960,000 | -9.1% | 24,630 | -7.1% | 0.04% | +14.3% |
| Q4 2021 | $1,056,000 | +12.1% | 26,499 | +1.6% | 0.04% | +9.4% |
| Q3 2021 | $942,000 | +208.9% | 26,073 | +250.5% | 0.03% | +220.0% |
| Q2 2021 | $305,000 | +4.5% | 7,439 | +11.3% | 0.01% | -9.1% |
| Q1 2021 | $292,000 | -17.5% | 6,685 | -5.4% | 0.01% | -26.7% |
| Q4 2020 | $354,000 | +28.3% | 7,069 | +7.6% | 0.02% | +7.1% |
| Q3 2020 | $276,000 | – | 6,569 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |